Clinical Trial Update: Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

View source ↗

Summary

An observational, non-interventional study sponsored by Tenaya Therapeutics to assess pre-existing antibodies against AAV9 and disease progression in patients w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arrhythmogenic Right Ventricular Cardiomyopathy

Snippet

Sponsor: Tenaya Therapeutics | Conditions: Arrhythmogenic Right Ventricular Cardiomyopathy | Status: RECRUITING